DBD is a generic pharmaceutical company in Vietnam with a market share of ~1% in 2020, per
our estimate based on data from IQVIA — a US market research company. The company is also the leading Vietnamese company in anti-cancer medicines (12% of DBD’s 2020 in-house product revenue) with a ~2% category share in the 12-month period ending June 2020.